Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:38 PM
Ignite Modification Date:
2025-12-25 @ 2:28 PM
NCT ID:
NCT02595866
Group ID:
EG000
Title:
Cohort 1 (Pembrolizumab and cART)
Description:
Participants enrolled into Cohort 1 (50-199 CD4+ T cells/mcL), who receive pembrolizumab IV over 30 minutes on day 1. Participants continue receiving their recommended combination antiretroviral therapy per established regimen. Cycles repeat every 21 days for up to 2 years or 35 doses in the absence of disease progression or unacceptable toxicity. Participants also undergo CT or PET/CT and blood sample collection throughout the trial. Participants may also undergo biopsies during screening and on study.
Antiretroviral Therapy: Given PO
Biopsy: Undergo biopsy
Biospecimen Collection: Undergo blood sample collection
Computed Tomography: Undergo CT or PET/CT
Pembrolizumab: Given IV
Positron Emission Tomography: Undergo PET/CT
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
10
Other Number Affected:
10
Other Number At Risk:
10
Study:
NCT02595866
Results Section:
NCT02595866
Adverse Events Module:
NCT02595866